Loading
LifeTech Scientific Corporation Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Fang Yu, was filed 12 May 2026.
Insider Decl.
31
Thresholds
n/a
Buy Volume
€5M
11 ops. · all time
Sell Volume
€64M
10 ops. · all time
Who traded when
BuySaleLiu Jianxiong2 buys1 sale
Fang Yu1 buy1 sale
Feng Xiaoling1 buy1 sale
Wu Liping1 buy1 sale
Xie Yuehui2 sales
Since the insiders bought
- -24.6%Entry HK$2.05 · Close 21 Oct 2026 HK$1.54
- -24.6%Entry HK$2.05 · Close 21 Oct 2026 HK$1.54
- -24.6%Entry HK$2.05 · Close 21 Oct 2026 HK$1.54
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 9,709 of 26,286 companies
58.0
score / 100
Value44
Quality72
FCF yld6.0%
Earn yld2.2%
EV/EBITDA22.7x
ROE0.6%
Gross mgn74%
Net mgn11%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$1.53
Analyst consensus
1 analystsHK$2.78Target HK$2.78(+82%)HK$2.78
Income statement
RevenueHK$1.4B
Gross profitHK$1B74% margin
EBITDAHK$294.8M22% margin
Net incomeHK$147.8M4.5% margin
Valuation
PER (trailing)153.0x
P/Book1.8x
Beta0.31
Balance sheet & cash
Market capHK$6.7B
Total debtHK$8M
Free Cash FlowHK$399M
Debt / Equity0%
Profitability & ownership
ROE0.6%
ROA2.3%
% insiders22.5%
% institutions7.4%
Last declaration on 28 September 2026
Declarations31 total
45,000,000 sharesShareXHKGHKEX:DA20260925E00450
7,333,333 sharesShareXHKGHKEX:DA20260519E00427
7,266,666 sharesShareXHKGHKEX:DA20260519E00431
16,666,666 sharesShareXHKGHKEX:DA20260519E00425
5,333,333 sharesShareXHKGHKEX:DA20260519E00435
22,000,000 sharesShareXHKGHKEX:DA20260511E00444
Canonical exit: 5 Aug 2026 (T+90)
16,000,000 sharesShareXHKGHKEX:DA20260511E00445
Canonical exit: 5 Aug 2026 (T+90)
21,800,000 sharesShareXHKGHKEX:DA20260511E00443
Canonical exit: 5 Aug 2026 (T+90)
50,000,000 sharesShareXHKGHKEX:DA20260511E00447
Canonical exit: 5 Aug 2026 (T+90)
75,000,000 sharesShareXHKGHKEX:DA20260408E00565
76,000,000 sharesShareXHKGHKEX:DA20260408E00570
74,535,662 sharesShareXHKGHKEX:DA20260408E00572
25,318,000 shares@ HK$1.6399.6% of flowShareXHKGHKEX:DA20251212E00400
Canonical exit: 12 Mar 2026 (T+90)
230,000,000 shares@ HK$1.9074.6% of flowShareXHKGHKEX:DA20251212E00399
135,870,000 sharesShareXHKGHKEX:DA20251125E00053
125,700,000 sharesShareXHKGHKEX:DA20251125E00054
130,650,000 sharesShareXHKGHKEX:DA20251125E00056
4,600,000 sharesShareXHKGHKEX:DA20251125E00049
16,800,000 sharesShareXHKGHKEX:DA20250604E00171
19,600,000 sharesShareXHKGHKEX:DA20250604E00176
4,600,000 sharesShareXHKGHKEX:DA20241216E00023
66,000,000 shares@ HK$1.5018.3% of flowShareXHKGHKEX:DA20240703E00544
21,720,000 shares@ HK$1.757.1% of flowShareXHKGHKEX:DA20240415E00516
36,000,000 sharesShareXHKGHKEX:DA20240129E00084
Canonical exit: 23 Apr 2024 (T+90)
4,600,000 sharesShareXHKGHKEX:DA20240129E00081
Canonical exit: 23 Apr 2024 (T+90)
25 of 31 declarations
About LifeTech Scientific Corporation
On December 12, 2025, Xie Yuehui, Director at LifeTech Scientific Corporation, filed a sale of EUR 47,833,582, the largest in the record, the day Liu Jianxiong, Director, filed a purchase of EUR 4,517,191. Xie Yuehui also sold EUR 11,744,370 on July 3, 2024 and EUR 4,568,612 on April 15, 2024. The sales, of which only 3 carry an amount, total EUR 64.1 million across 10 sales.
On the purchase side, 11 filings, 2 of them with an amount, worth EUR 4.5 million: the Liu Jianxiong purchase of December 12, 2025 and another of EUR 20,141 by the same filer on November 14, 2019. Purchases make up 52% of open-market trades. On May 7, 2026, four insiders filed a purchase on the same day, with no amount published.
Read moreShow less
Xie Yuehui and Liu Jianxiong file 8 each, Wu Liping, Feng Xiaoling and Fang Yu 4 each. Of 31 filings, 10 are of another kind. Annual volume is 3 in 2018, 5 in 2024, 8 in 2025 and 12 in 2026. The last twelve months hold 18 filings, of which 5 purchases and 4 sales. The Hong Kong company, classed in Health Care, is worth HKD 6.73 billion, with 22.5% of the shares held by insiders. Filings come out a median of 5 days after the trade.
